Because cumulative exposure to cancer therapies is a major determinant of cardiotoxic effects, we further hypothesized that CHIP amplifies this risk, with a greater effect among those receiving higher cumulative chemotherapy exposure. This evidence concerns the gene STUB1 and cancer.